| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $563K | — | +185.8% |
| Cost of Revenue | $84K | — | -10.6% |
| Gross Profit | $479K | — | +365.0% |
| R&D Expense | $1.2M | — | -25.2% |
| SG&A Expense | $2.7M | — | +73.1% |
| Operating Income | -$3.5M | — | -11.5% |
| Income Tax | $0 | — | — |
| Net Income | -$3.5M | — | -45.5% |
| EPS (Basic) | -$0.09 | — | -12.5% |
| EPS (Diluted) | -$0.09 | — | -12.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.4M | +76.0% | -15.2% |
| Accounts Receivable | $280K | +101.4% | +15.7% |
| Inventory | $379K | +100.5% | — |
| Current Assets | $13.7M | +73.8% | -12.9% |
| Total Assets | $14.0M | +72.5% | -12.8% |
| Current Liabilities | $1.9M | -2.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | -9.7% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $9.0M | — | -16.3% |
| Free Cash Flow | -$3.7M | — | -9.6% |
| +10.6% |
| Total Liabilities | $2.7M | +1.0% | -5.5% |
| Stockholders' Equity | $11.3M | +107.8% | -14.4% |